CARASENT ASA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.65 NOK | -0.80% |
|
+72.69% | +68.63% |
| 29/04 | Carasent’s Board Rejects EG Norge's Takeover Bid Plans | MT |
| 29/04 | Eg Norge A/S contemplates launching a voluntary cash offer to acquire Carasent ASA (OB:CARA) for NOK 1.4 billion. | CI |
| Sales 2024 * | 270M 24.47M 2.04B | Sales 2025 * | 320M 29M 2.42B | Capitalization | 1.35B 122M 10.2B |
|---|---|---|---|---|---|
| Net income 2024 * | -1M -90.64K -7.56M | Net income 2025 * | 13M 1.18M 98.34M | EV / Sales 2024 * | 3.72 x |
| Net cash position 2024 * | 344M 31.14M 2.6B | Net cash position 2025 * | 315M 28.55M 2.38B | EV / Sales 2025 * | 3.23 x |
| P/E ratio 2024 * |
-933
x | P/E ratio 2025 * |
98.2
x | Employees | 165 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 68.01% |
More Fundamentals
* Assessed data
More news
Latest transcript on Carasent ASA
More press releases
| 1 day | -0.80% | ||
| 1 week | +72.69% | ||
| Current month | +61.89% | ||
| 1 month | +61.89% | ||
| 3 months | +76.28% | ||
| 6 months | +37.13% | ||
| Current year | +68.63% |
1 week
13.15
19.60
1 month
10.4019.60
Current year
9.8119.60
1 year
9.8119.60
3 years
9.8151.00
5 years
4.7651.00
10 years
2.0051.00
| Managers | Title | Age | Since |
|---|---|---|---|
Daniel Öhman
CEO | Chief Executive Officer | 44 | 01/22/01 |
| Director of Finance/CFO | 34 | 01/21/01 | |
Shane Smith
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 63 | 19/22/19 | |
Camilla Skoog
BRD | Director/Board Member | 51 | 28/22/28 |
Ulrika Sundling
BRD | Director/Board Member | - | 28/22/28 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/24/30 | 18.65 | -0.80% | 170,855 |
| 29/24/29 | 18.8 | +31.47% | 1,349,203 |
| 26/24/26 | 14.3 | -4.67% | 211,090 |
| 25/24/25 | 15 | +1.69% | 74,447 |
| 24/24/24 | 14.75 | +34.09% | 699,828 |
Real-time Oslo Bors, April 30, 2024 at 08:15 pm IST
More quotes
Carasent ASA is a Norway-based technology Company. The strategy of Carasent is to develop and expand digitalization that helps customers to meet challenges in providing efficient and qualitative health care services. The Company provides its customers with cloud based medical record software solutions and a broad ecosystem of integrated services, in a range of healthcare segments. Carasent focuses on businesses that develop entrepreneurial and e-health solutions. Operating business activities in the Group can be categorized into six different categories; Software as a Service (SaaS), Add-on services, Consulting, License, maintenance and other. All services are delivered to the health care sector.
Sector
IT Services & Consulting
Calendar
12/07/2024
- Q2 2024 Earnings Call
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +68.63% | 122M | |
| -14.89% | 189B | |
| +0.72% | 166B | |
| +0.46% | 152B | |
| +6.16% | 99.37B | |
| +6.11% | 77.36B | |
| +15.71% | 70.76B | |
| -7.93% | 70.46B | |
| -21.54% | 51.83B | |
| -6.79% | 44.34B |
- Stock Market
- Equities
- CARA Stock
